STRIDES PHARMA SCIENCE Plunges by 5%; BSE HEALTHCARE Index Down 0.8%
October 9, 2019 09:46 AM

STRIDES PHARMA SCIENCE share price has plunged 5% and is presently trading at Rs 311.

Meanwhile, the BSE HEALTHCARE Index is at 12,011 (down 0.8%).

Among the top losers in the BSE HEALTHCARE Index today are STRIDES PHARMA SCIENCE (down 5.5%) and PIRAMAL ENTERPRISES (down 7.7%).

NARAYANA HRUDAYALAYA LTD (up 2.3%) and BLISS GVS PHARMA (up 1.5%) are among the top gainers today.

Over the last one year, STRIDES PHARMA SCIENCE has moved down from Rs 407 to Rs 311, registering a loss of Rs 96 (down 23.5%)..

The BSE HEALTHCARE has moved down from 14,271 to 12,011, loss of 2,260 points (down 15.8%) during the last 12 months.

The top gainers among the BSE HEALTHCARE Index stocks during this same period were PROCTER & GAMBLE HEALTH (up 67.1%), ABBOTT INDIA (up 49.2%) and IPCA LABS (up 41.5%).

What About the Benchmark Indices?

The BSE Sensex is at 37,663 (up 0.2%). The top gainers among the BSE Sensex stocks today are KOTAK MAHINDRA BANK (up 1.3%). The most traded stocks in the BSE Sensex are ICICI BANK and M&M.

In the meantime, NSE Nifty is at 11,159 (up 0.1%). ULTRATECH CEMENT (up 2.7%) and KOTAK MAHINDRA BANK (up 1.4%) are among the top gainers in NSE Nifty.

Over the last 12 months, the BSE Sensex has moved up from 34,474 to 37,663, registering a gain of 3,189 points (up 9.0%).

STRIDES PHARMA SCIENCE Financial Update...

STRIDES PHARMA SCIENCE net profit stood at Rs 432 million for the quarter ended June 2019, compared to a profit of Rs 316 million a year ago. Net Sales declined 13.7% to Rs 6.9 billion during the period as against Rs 7.9 billion in April-June 2018.

For the year ended March 2018, STRIDES PHARMA SCIENCE reported 58.6% decrease in net profit to Rs 1.3 billion compared to net profit of Rs 3.2 billion during FY17.

Revenue of the company grew 3.0% to Rs 28 billion during FY18.

The current Price to earnings ratio of STRIDES PHARMA SCIENCE, based on rolling 12 month earnings, stands at 18.0x.